anubhai
Back OfficeNippon India Pharma Fund - Direct (G)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund - Direct (G) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 01-Jan-2013 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 8,458.68 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 0.61 | -0.60 | -0.49 | 1.70 | 0.48 | 22.55 | 16.49 | 17.59 |
| Category Avg | 0.70 | -0.71 | -1.26 | 3.00 | -0.18 | 22.95 | 16.05 | 14.04 |
| Category Best | 1.25 | 0.54 | 0.60 | 6.92 | 6.41 | 28.97 | 19.11 | 29.66 |
| Category Worst | 0.13 | -1.49 | -3.77 | -2.08 | -6.79 | 18.88 | 12.05 | -5.32 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 13.55 |
| Lupin | 7.59 |
| Divi's Lab. | 6.90 |
| Cipla | 6.33 |
| Dr Reddy's Labs | 5.83 |
| Apollo Hospitals | 5.63 |
| Medplus Health | 3.47 |
| Vijaya Diagnost. | 3.41 |
| Ajanta Pharma | 2.90 |
| Glaxosmi. Pharma | 2.77 |
| Gland Pharma | 2.75 |
| Sai Life | 2.67 |
| Thyrocare Tech. | 2.57 |
| Aurobindo Pharma | 2.47 |
| Abbott India | 2.44 |
| Dr Lal Pathlabs | 2.20 |
| Alkem Lab | 2.18 |
| Narayana Hrudaya | 2.12 |
| J B Chemicals & | 2.09 |
| Mankind Pharma | 2.02 |
| Biocon | 1.99 |
| Ipca Labs. | 1.93 |
| Pfizer | 1.87 |
| Suraksha Diagno. | 1.35 |
| Emcure Pharma | 1.24 |
| Max Healthcare | 1.23 |
| Fortis Health. | 1.20 |
| Sanofi India | 1.19 |
| Sanofi Consumer | 1.18 |
| Syngene Intl. | 0.98 |
| Anthem Bioscienc | 0.79 |
| Akums Drugs | 0.76 |
| Astrazeneca Phar | 0.67 |
| Indoco Remedies | 0.56 |
| Orchid Pharma | 0.45 |
| Concord Biotech | 0.19 |
| TREPS | 0.71 |
| Net CA & Others | -0.18 |
| C C I | 0.00 |
